IBM agreed to sell part of its IBM Watson Health business to private equity firm Francisco Partners, scaling back the technology company’s once-lofty ambitions in health care. From a report: The value of the assets being sold, which include extensive and wide-ranging data sets and products, and image software offerings, is more than $1 billion, according to people familiar with the plans. The deal “is a clear next step as IBM becomes even more focused on our platform-based hybrid cloud and AI strategy,” said Tom Rosamilia, senior vice president, IBM Software. “IBM remains committed to Watson, our broader AI business, and to the clients and partners we support in healthcare IT.” IBM launched Watson Health in 2015 with the aim of using its core artificial intelligence platform to help health care providers analyze troves of data and ultimately revolutionize cancer treatment. Many of the company’s ambitions haven’t panned out, though,